Exela Technologies, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
Exela Technologies exchanged 1,525,666 shares of Series A Preferred Stock for 21,385,694 shares of common stock, impacting the company's capital structure.
OTC.Pink
Exela Technologies will be delisted from the Nasdaq Stock Market and will begin trading on the OTC Markets system after failing to regain compliance with minimum market value requirements.
OTC.Pink
Exela Technologies reports the resignations of two board members, Marc A. Beilinson and Sharon Chadha, effective October 3, 2024.
OTC.Pink
8-K: Exela Technologies Reports Mixed Second Quarter Results with Revenue Decline but Improved Margins
Exela Technologies reported a 10% year-over-year revenue decrease for the second quarter of 2024, alongside improved gross margins and a reduced net loss.
OTC.Pink
Exela Technologies has filed a Certificate of Elimination to retire all previously redeemed shares of its Special Voting Preferred Stock.
OTC.Pink
Exela Technologies has successfully regained compliance with Nasdaq listing rules after addressing issues related to minimum equity and holding its annual shareholder meeting.
OTC.Pink
Exela Technologies is exploring a spin-off of its business process automation (BPA) business to maximize shareholder value.
OTC.Pink
Exela Technologies' stockholders approved a new stock incentive plan and elected directors at their annual meeting, but rejected a proposal to amend the terms of their Series B Preferred Stock.
OTC.Pink
8-K: Exela Technologies Reports Improved Operating Profit and Reduced Net Loss in Full Year 2023 Results
Exela Technologies announced its full year 2023 results, showing improved operating profit and a reduced net loss despite a slight revenue decrease.
OTC.Pink
Exela Technologies received a notice from Nasdaq for failing to hold its annual shareholder meeting within the required timeframe, putting its listing status at risk.